Through the 90-day period concluding December 12, 2025, Vertex Pharmaceuticals's top three insider stakeholders include EVP And COO Stuart A Arbuckle (63.37K shares), EVP And Chief Reg. & Quality Off. Ourania Tatsis (46.79K shares), EVP And Co & Fo Charles F Jr Wagner (37.73K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Reshma Kewalramani | CEO & President | 115,968 | 07 Aug, 2025 |
| Amit Sachdev | EVP Chief Patient & Ext Af Off | 68,490 | 28 Feb, 2025 |
| Stuart A Arbuckle | EVP And COO | 63,368 | 02 Jul, 2025 |
| Ourania Tatsis | EVP And Chief Reg. & Quality Off. | 46,793 | 05 Dec, 2025 |
| Bruce I Sachs | 45,000 | 07 Aug, 2025 | |
| Charles F Jr Wagner | EVP And Co & Fo | 37,725 | 05 Dec, 2025 |
| Carmen Bozic | EVP And Cmo | 32,669 | 28 Feb, 2025 |
| Bastiano Sanna | EVP And Cell & Genetic Therapies | 32,038 | 09 May, 2023 |
| Michael Parini | EVP And Chief Adm And Leg & Bd Off | 30,837 | 26 Feb, 2021 |
| Jeffrey M Leiden | Executive Chairman | 24,027 | 05 Dec, 2025 |
| David Altshuler | EVP And Chief Scientific Officer | 23,281 | 19 May, 2025 |
| Edward Morrow Iii Atkinson | EVP And Chief Technical Ops. Off. | 16,852 | 19 Nov, 2025 |
| Jonathan Biller | EVP And Chief Legal Officer | 15,306 | 05 Dec, 2025 |
| Paul M Silva | SVP & Chief Accounting Officer | 9,884 | 02 Mar, 2021 |
| Joy Liu | SVP And General Counsel | 9,605 | 17 Aug, 2022 |
| Kristen Ambrose | SVP & Chief Accounting Officer | 7,845 | 28 Feb, 2025 |
| Alan M Garber | 6,872 | 05 May, 2025 | |
| Terrence C Kearney | 6,536 | 14 Aug, 2023 | |
| Lloyd Carney | 6,315 | 20 Nov, 2025 | |
| Sangeeta N. Bhatia | 4,565 | 29 Aug, 2025 | |
| Suketu Upadhyay | 2,354 | 05 May, 2025 | |
| Diana Mckenzie | 2,231 | 05 May, 2025 | |
| Nancy Thornberry | 2,035 | 05 May, 2025 | |
| Yuchun Lee | 1,875 | 31 Jan, 2023 | |
| Jennifer Schneider | 1,718 | 05 May, 2025 | |
| Michel Lagarde | 1,132 | 10 Oct, 2023 | |
| Margaret G Mcglynn | 178 | 03 May, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Dec, 2025 | Jonathan Biller | Common Stock | D | 347 | $449.00 | 15,306 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | A | 63,781 | $86.52 | 87,807 | D | M |
| 03 Dec, 2025 | Ourania Tatsis | Common Stock | D | 4,500 | $449.99 | 46,793 | D | S |
| 03 Dec, 2025 | Charles F Jr Wagner | Common Stock | D | 7,000 | $451.00 | 44,725 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 4,469 | $440.40 | 83,338 | D | S |
| 03 Dec, 2025 | Charles F Jr Wagner | Common Stock | D | 7,000 | $461.00 | 37,725 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 1,320 | $441.26 | 82,018 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 2,469 | $443.21 | 79,549 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 4,352 | $444.36 | 75,197 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 7,899 | $445.56 | 67,298 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 1,152 | $447.05 | 66,146 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 2,320 | $448.78 | 63,826 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 5,880 | $449.84 | 57,946 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 5,809 | $451.20 | 52,137 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 15,681 | $452.20 | 36,456 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 10,360 | $453.34 | 26,096 | D | S |
| 03 Dec, 2025 | Jeffrey M Leiden | Common Stock | D | 2,070 | $455.22 | 24,026 | D | S |
| 04 Dec, 2025 | Jeffrey M Leiden | Common Stock | A | 1 | $91.05 | 24,027 | D | M |
| 19 Nov, 2025 | Lloyd Carney | Common Stock | D | 800 | $0.00 | 6,315 | D | G |
| 17 Nov, 2025 | Edward Morrow Iii Atkinson | Common Stock | D | 2,500 | $434.58 | 16,852 | D | S |